136 related articles for article (PubMed ID: 26234135)
1. [Expression and antitumor activity of fusion protein RGD-TRAIL in Pichia pastoris].
Wang XF; Chen SZ
Yao Xue Xue Bao; 2015 May; 50(5):552-9. PubMed ID: 26234135
[TBL] [Abstract][Full Text] [Related]
2. RGD and NGR modified TRAIL protein exhibited potent anti-metastasis effects on TRAIL-insensitive cancer cells in vitro and in vivo.
Wang X; Qiao X; Shang Y; Zhang S; Li Y; He H; Chen SZ
Amino Acids; 2017 May; 49(5):931-941. PubMed ID: 28236246
[TBL] [Abstract][Full Text] [Related]
3. [Cloning and recombinant expression of human soluble TRAIL in Pichia pastoris].
Li Y; Wan L; Yang H; Liu S; Cai H; Lu X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1307-11, 1326. PubMed ID: 21374984
[TBL] [Abstract][Full Text] [Related]
4. Induction of non-small cell lung carcinoma apoptosis using soluble RGD-TRAIL by targeting the integrin receptor of tumor cells.
Yao R; Sui A; Wang Z; Liu S; Zhou Q; Liu X; Zhang H
Mol Med Rep; 2012 Dec; 6(6):1355-60. PubMed ID: 22965279
[TBL] [Abstract][Full Text] [Related]
5. [Expression of a DNA fragment encoding the active domain of human TNF related apoptosis inducing ligand in pichia pastoris].
Xu H; Lai XT; Ye K; Ma HW; Hong K
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):163-7. PubMed ID: 15966315
[TBL] [Abstract][Full Text] [Related]
6. A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity.
Zhu D; Wang X; Shang Y; Li Y; Jiang W; Li L; Chen SZ
Anticancer Drugs; 2015 Jan; 26(1):64-73. PubMed ID: 25122444
[TBL] [Abstract][Full Text] [Related]
7. TRAIL-CM4 fusion protein shows in vitro antibacterial activity and a stronger antitumor activity than solo TRAIL protein.
Sang M; Zhang J; Li B; Chen Y
Protein Expr Purif; 2016 Jun; 122():82-9. PubMed ID: 26926590
[TBL] [Abstract][Full Text] [Related]
8. Fused hydrophobic elastin-like-peptides (ELP) enhance biological activity of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Huang K; Duan N; Zou W; Zhang C; Lai Y; Shen P; Hua Z
Protein Pept Lett; 2015; 22(11):1000-6. PubMed ID: 26299999
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculature.
Cao L; Du P; Jiang SH; Jin GH; Huang QL; Hua ZC
Mol Cancer Ther; 2008 Apr; 7(4):851-61. PubMed ID: 18413798
[TBL] [Abstract][Full Text] [Related]
10. [Expression of anti-gp96 scFv fragment in Pichia pastoris and identification of its biological activity].
Gui M; Wu H; Sun L; Xu Y; Zhao B; Li X; Li C; Wang X; Meng S
Sheng Wu Gong Cheng Xue Bao; 2014 Apr; 30(4):595-604. PubMed ID: 25195249
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
Wang Y; He L; He G; Kong Y; Liu X; Cai H; Liu X; Tan W
Sheng Wu Gong Cheng Xue Bao; 2010 Jun; 26(6):780-8. PubMed ID: 20815258
[TBL] [Abstract][Full Text] [Related]
12. Potent antitumor effect elicited by RGD-mda-7, an mda-7/IL-24 mutant, via targeting the integrin receptor of tumor cells.
Zhang BF; Liu JJ; Pei DS; Yang ZX; Di JH; Chen FF; Li HZ; Xu W; Wu YP; Zheng JN
Cancer Biother Radiopharm; 2011 Oct; 26(5):647-55. PubMed ID: 21902545
[TBL] [Abstract][Full Text] [Related]
13. Improved antitumor activity of TRAIL fusion protein via formation of self-assembling nanoparticle.
Huang K; Duan N; Zhang C; Mo R; Hua Z
Sci Rep; 2017 Feb; 7():41904. PubMed ID: 28225020
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of human tumor necrosis factor-related apoptosis inducing ligand in methylotrophic yeast Pichia pastoris.
Wang J; Chen J; Wu M
Ital J Biochem; 2004 Jul; 53(2):67-72. PubMed ID: 15646010
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the purification of biologically active IL-7 cytokine expressed in Escherichia coli and Pichia pastoris.
Zaremba-Czogalla M; Stumpp C; Bonifacio E; Paul R
Protein Expr Purif; 2015 Jun; 110():65-71. PubMed ID: 25703052
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of RGD tumour-homing-peptide-modified plasminogen K5.
Wang Y; Guo Z; Ge Q; Wang E; Zhang X; Jin G
Biotechnol Appl Biochem; 2010 Sep; 57(1):17-24. PubMed ID: 20718711
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
18. Linker length affects expression and bioactivity of the onconase fusion protein in Pichia pastoris.
Yang GG; Xu XY; Ding Y; Cui QQ; Wang Z; Zhang QY; Shi SH; Lv ZY; Wang XY; Zhang JH; Zhang RG; Xu CS
Genet Mol Res; 2015 Dec; 14(4):19360-70. PubMed ID: 26782589
[TBL] [Abstract][Full Text] [Related]
19. High-level expression, purification and study of bioactivity of fusion protein M-IL-2((88)Arg, (125)Ala) in Pichia pastoris.
Li L; Qian D; Shao G; Yan Z; Li R; Hua X; Song X; Wang B
Protein Expr Purif; 2014 Sep; 101():99-105. PubMed ID: 24955549
[TBL] [Abstract][Full Text] [Related]
20. Engineered adenovirus fiber shaft fusion homotrimer of soluble TRAIL with enhanced stability and antitumor activity.
Yan J; Wang L; Wang Z; Wang Z; Wang B; Zhu R; Bi J; Wu J; Zhang H; Wu H; Yu B; Kong W; Yu X
Cell Death Dis; 2016 Jun; 7(6):e2274. PubMed ID: 27336718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
